(Q40707257)

22 September 2017

title

B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

22 September 2017

main subject

1 reference

Teruki Miyake

1

1 reference

22 September 2017

Masanori Abe

2

1 reference

22 September 2017

Yoshio Tokumoto

3

1 reference

22 September 2017

Masashi Hirooka

4

1 reference

22 September 2017

Shinya Furukawa

5

1 reference

22 September 2017

Teru Kumagi

6

1 reference

22 September 2017

Maho Hamada

7

1 reference

22 September 2017

Keitarou Kawasaki

8

1 reference

22 September 2017

Fujimasa Tada

9

1 reference

22 September 2017

Teruhisa Ueda

10

1 reference

22 September 2017

Yoichi Hiasa

11

1 reference

22 September 2017

Bunzo Matsuura

12

1 reference

22 September 2017

Morikazu Onji

13

1 reference

22 September 2017

publication date

9 February 2012

1 reference

22 September 2017

published in

Hepatology international

1 reference

22 September 2017

volume

7

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

539-547

1 reference

Nonalcoholic fatty liver disease

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Inflammatory mechanisms in the regulation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

BAFF, APRIL and their receptors: structure, function and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

B cell-activating factor controls the production of adipokines and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Relationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki Prefectural Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Splanchnic lipolysis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Pathogenesis of non-alcoholic steatohepatitis: human data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Appropriateness of liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9345-8

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

12 December 2020

Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells

1 reference

12 December 2020

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver: a follow-up study

1 reference

12 December 2020

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance

1 reference

12 December 2020

Natural history of NAFLD: remarkably benign in the absence of cirrhosis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

12 December 2020

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement

1 reference

12 December 2020

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

1 reference

12 December 2020

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease

1 reference

12 December 2020

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

1 reference

12 December 2020

Synthesis and release of B-lymphocyte stimulator from myeloid cells

1 reference

12 December 2020

10.1007/S12072-012-9345-8

Identifiers

DOI

1 reference

22 September 2017

1 reference